FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review

The FDA has approved halobetasol propionate lotion as a topical treatment for plaque psoriasis...

Source: The Rheumatologist - December 3, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates dermatitis dupilumab FDA halobetasol propionate lotion plaque psoriasis U.S. Food and Drug Administration (FDA) Source Type: research